Michel “Mike” Morency Ph.D. - Boston, MA

As President and CEO of NF2 BioSolutions, I would like to recommend Dr. Mike Morency without reservation to any organization seeking a strategic, hands‑on intellectual property and transactions leader who thinks like an operator and executes like a seasoned attorney. Few combine deep scientific fluency with seasoned transactional judgment the way Mike does. He initially represented an investor in our organization and now represents NF2 BioSolutions directly. Across both roles, he has consistently protected our mission and strengthened our position with the kind of practical, business‑forward counsel that moves therapies closer to patients. One moment in particular crystallized Mike’s diligence and integrity. During a collaborator’s patent filing, I was inadvertently omitted as an inventor on a patent family. Mike was the only professional who spotted the error. He moved methodically to correct the record and ensure that I was added as an inventor — an action that was not only legally correct, but vital to aligning incentives and providing the company with leverage and flexibility. That episode exemplifies his attention to detail, his command of inventorship standards, and his unwavering commitment to doing what is right. Mike’s background — Ph.D. in Medical Science/Neuroscience paired with decades of IP and corporate experience in life sciences — shows up in every interaction. He quickly grasps complex biology, device concepts, and gene‑ and cell‑based modalities; he then translates them into cost‑effective IP strategies that withstand diligence and accelerate collaborations. Equally important, he takes the time to educate our team on the nuances of each IP path — claim scope, freedom‑to‑operate, trade‑offs between provisional filings and data readiness, portfolio sequencing around funding milestones — so decisions are confident and aligned. Beyond patents, Mike is an expert partner on the full range of transactions that a rare‑disease nonprofit navigates with academic and industry collaborators. He is skilled at structuring licenses, sponsored research agreements, and strategic alliances that balance speed with protection. His feedback is clear, his drafts are crisp, and his negotiation style is collegial but firm—focused on outcomes that endure. NF2 BioSolutions exists to advance next‑generation technologies — including gene therapy and immunotherapy — to change the trajectory of Neurofibromatosis Type 2. That mission requires counsel who can see both the science and the market. Mike is that counsel. He has been an exceptional ally to me personally and an invaluable asset to NF2 BioSolutions.

I’m pleased to recommend Dr. Mike Morency for his exceptional counsel in intellectual property strategy. He combines deep scientific expertise with sharp business acumen. As a registered U.S. patent attorney with a Ph.D. in Medical Sciences, Mike translates complex science into clear, defensible IP that aligns with strategic goals—whether for financing, partnerships, or market access. He takes the time to explain IP strategy, enabling informed, high-impact decisions across technical, legal, and commercial teams. With over 30 years of experience guiding life-science innovators from discovery to commercialization, Mike has helped evaluate and protect core inventions, assess risks, and structure agreements that accelerate development while preserving long-term value. His counsel is pragmatic and cost-effective, focusing on what truly matters. Responsive, composed, and proactive, Mike is a true partner—candid, outcome-driven, and deeply committed. I recommend him without hesitation.

When we engaged Dr. Morency, our target formulation sat inside a broad PCT with weak, non‑novel claims. Mike rolled up his sleeves. First, he delivered a clear-eyed prior‑art analysis and mapped precisely why the then‑pending claims wouldn’t hold. Next, he redesigned the claim strategy to align with the actual technical advantages of our formulation. Under his guidance, prosecution shifted from aspirational to achievable—focused amendments, strong support in the specification, and examiner engagement that anticipated concerns rather than reacting to them. The results speak for themselves. We obtained a U.S. patent covering our commercial formulation and advanced our own PCT with a favorable written opinion on novelty and inventive step, opening a path to international protection. What I value most is his blend of scientific fluency and commercial pragmatism: he tells you what must be true for patentability, then helps the team generate the data and narrative to make it true. He is responsive, candid on costs, and relentless about building a coherent story from patents to trademarks to regulatory. Mike turned a shaky IP posture into a defensible moat and did it on startup timelines and budgets. He communicates trade-offs clearly and moves negotiations forward without compromising what truly drives value.

As co-founder of an early-stage proteomics company, I have had the privilege of working closely with Dr. Morency on a variety of intellectual property and transactional matters critical to the success and growth of our biotechnology startup. From the outset, Dr. Morency distinguished himself through his deep scientific expertise, combined with an exceptional understanding of complex legal frameworks. His unique background in both medical sciences and law gives him the rare ability to translate highly technical innovations into strong, defensible intellectual property assets. In my company’s case, he not only guided us in building a cost-effective and strategically sound IP portfolio but also ensured that our innovations were positioned to withstand rigorous due diligence by potential partners and investors. What sets Dr. Morency apart is his business-minded approach to intellectual property. He understands that, for both established and emerging life sciences companies, IP is not just about protection, but also about creating leverage for financing, partnering, and commercialization, ultimately providing for long-term stability and growth. His skill in structuring, negotiating, and executing licensing agreements and collaborative transactions has been invaluable to our progress. Moreover, his responsiveness, attention to detail, and ability to anticipate challenges have given me great confidence in every decision we’ve made together, including addressing future directions. Beyond his professional acumen, Dr. Morency is an absolute pleasure to work with. He brings clarity to complex issues, is generous with his time, and demonstrates genuine commitment to the success of his clients. His uniquely coupled training and experience in science (Ph.D.) and law, enable him to communicate equally effectively with both researchers and management, ensuring all are comfortable and fully informed about the necessary processes for their specific circumstances. I am extremely pleased with his services and thus wholeheartedly recommend him to any organization seeking a trusted, strategic partner for their intellectual property and transactional needs.